- XIPERE Now Approved for Use in Multiple Global Markets -
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
Seeking Alpha / 3 hours ago 2 Views
Seeking Alpha / 3 hours ago 2 Views
- XIPERE Now Approved for Use in Multiple Global Markets -
Comments